Also known as: MT-1, MT1, Melanotan I, MT-I, Afamelanotide, Scenesse, NDP-alpha-MSH, CUV1647 Photoprotection and skin tanning via MC1R agonism (approved as afamelanotide for EPP) Amount 0.16 mg/kg daily (injection protocol)
Individual tolerance varies significantly based on genetics and prior medication history
This category has almost nothing to do with willpower or caloric math
The SURMOUNT-4 trial demonstrated that patients who discontinued tirzepatide after achieving weight loss regained significant weight compared to those who continued treatment, though not all weight loss was reversed during the study period
However, how they are administered and personal preference can largely dictate your choice
Allow vials that have been refrigerated to warm up at room temperature for 15 to 20 minutes before opening them